Diseases, Conditions, Syndromes

Scientists find promising vaccine targets on hepatitis C virus

A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.

Oncology & Cancer

Tremelimumab shows promise in treatment of liver cancer

Tremelimumab treatment stabilized patients with advanced hepatocellular carcinoma due to chronic hepatitis C infection for more than 12 months, according to data presented at the AACR Annual Meeting 2012, held here March ...

Diseases, Conditions, Syndromes

Liver disease deaths jump 25% in England: study

Deaths from liver disease have risen 25 percent in England in less than a decade, mainly due to increased alcohol consumption, a study revealed on Thursday.

Diseases, Conditions, Syndromes

Egyptians design 'faster, cheaper' hepatitis C test

The American University in Cairo said Wednesday that a team of its researchers has designed a faster and cheaper test for all types of hepatitis C, which it says affects about 10 million Egyptians.

Diseases, Conditions, Syndromes

Hypoferremia predicts treatment response to IFN-α

(HealthDay) -- For patients with hepatitis C virus (HCV), hepcidin, a regulator of iron homeostasis, is induced following a single dose of pegylated interferon-α (PEG-IFNα), and may be a surrogate marker of immediate ...

page 36 from 38